Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)
Clinical trial NCT03341637 · COMPLETED
Trial details
- NCT number
- NCT03341637
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-14
- Primary completion
- 2019-01-26
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.